NTRK1 and prostate adenocarcinoma: The cBioPortal was used to investigate the specific genetic alterations of NTRK1 (prognostically significant) and 21 other hub genes across the TCGA-PRAD messenger RNA (mRNA) cohort comprising 501 patient samples.